Clinical Trial Update: A Study to Test Whether BI 771716 Helps People With an Advanced Form of Age-related Macular Degeneration (AMD) Called Geographic Atrophy [Phase 2]

View source ↗

Summary

Phase 2 trial update of BI 771716 for geographic atrophy, a form of age-related macular degeneration, currently active_not_recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Age-related Macular Degeneration
• Geographic Atrophy

Drugs mentioned

• BI 771716

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Macular Degeneration, Age-related, Geographic Atrophy | Phase 2 | Status: ACTIVE_NOT_RECRUITING